Lumley, Catherine J Desale, Sameer Tefera, Eshetu Maxwell, Jessica H

Post-diagnosis aspirin use and survival in veterans with head and neck cancer. - 2018

Available online from MWHC library: 1996 - present

BACKGROUND: Our objective was to determine the effect of post-diagnosis aspirin use on survival in veterans with head and neck squamous cell carcinoma. METHODS: Retrospective cohort study of 584 veterans with head and neck squamous cell carcinoma treated at the Washington DC VA Medical Center between 1995 and 2015. Charts were queried for clinical-pathologic data, aspirin prescriptions, and outcome. The Kaplan-Meier method was used to determine overall survival (OS) and disease-specific survival (DSS) among aspirin users and nonusers. RESULTS: A total of 329 patients met inclusion criteria. Primary subsites included oropharynx (n = 143), larynx (n = 105), oral cavity (n = 62), and hypopharynx (n = 19). Eighty-four patients were aspirin users (25.5%). Aspirin users demonstrated significantly better 3-year OS and DSS (78.6% and 88.1%) compared to nonaspirin users (OS: 55.9% and DSS: 70.2%; P = .0003 and P = .0019, respectively). On multivariate analysis, aspirin use remained independently associated with improved survival. CONCLUSION: Aspirin use following diagnosis and curative treatment of head and neck squamous cell carcinoma is associated with improved OS and DSS. Copyright (c) 2018 Wiley Periodicals, Inc.


English

1043-3074

10.1002/hed.25518 [doi]


IN PROCESS -- NOT YET INDEXED


MedStar Health Research Institute
MedStar Washington Hospital Center


Otolaryngology


Journal Article

Powered by Koha